Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism - PubMed (original) (raw)

Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism

S Schultz-Cherry et al. J Cell Biol. 1993 Aug.

Erratum in

• J Cell Biol 1993 Sep;122(5):following 1143

Abstract

Thrombospondin (TSP) forms specific complexes with transforming growth factor-beta (TGF-beta) in the alpha granule releasate of platelets and these TSP-TGF-beta complexes inhibit the growth of bovine aortic endothelial cells (BAE). In these studies, we report that TSP stripped of associated TGF-beta (sTSP) retained growth inhibitory activity which was partially reversed by a neutralizing antibody specific for TGF-beta. Since BAE cells secrete latent TGF-beta, we determined whether sTSP activates the latent TGF-beta secreted by BAE cells. Cells were cultured with or without sTSP and then the conditioned medium was tested for the ability to support TGF-beta-dependent normal rat kidney (NRK) colony formation in soft agar. Medium conditioned with sTSP showed a dose- and time-dependent ability to stimulate BAE-secreted TGF-beta activity, reaching maximal activation by 1-2 h with 0.4 micrograms/ml (0.9 nM) sTSP. The sTSP-mediated stimulation of TGF-beta activity is not dependent on serum factors and is not a general property of extracellular matrix molecules. The sTSP-mediated stimulation of TGF-beta activity was blocked by a mAb specific for sTSP and by neutralizing antibodies to TGF-beta. Activation of BAE cell secreted latent TGF-beta by sTSP can occur in the absence of cells and apparently does not require interactions with cell surface molecules, since in conditioned medium removed from cells and then incubated with sTSP, activation occurs with kinetics and at levels similar to what is seen when sTSP is incubated in the presence of cells. Serine proteases such as plasmin are not involved in sTSP-mediated activation of TGF-beta. Factors that regulate the conversion of latent to active TGF-beta are keys to controlling TGF-beta activity. These data suggest that TSP is a potent physiologic regulator of TGF-beta activation.

PubMed Disclaimer

Similar articles

• Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.
  Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE. Schultz-Cherry S, et al. J Biol Chem. 1994 Oct 28;269(43):26775-82. J Biol Chem. 1994. PMID: 7929413
• The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
  Schultz-Cherry S, Lawler J, Murphy-Ullrich JE. Schultz-Cherry S, et al. J Biol Chem. 1994 Oct 28;269(43):26783-8. J Biol Chem. 1994. PMID: 7929414
• Transforming growth factor-beta complexes with thrombospondin.
  Murphy-Ullrich JE, Schultz-Cherry S, Höök M. Murphy-Ullrich JE, et al. Mol Biol Cell. 1992 Feb;3(2):181-8. doi: 10.1091/mbc.3.2.181. Mol Biol Cell. 1992. PMID: 1550960 Free PMC article.
• Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.
  Murphy-Ullrich JE, Poczatek M. Murphy-Ullrich JE, et al. Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):59-69. doi: 10.1016/s1359-6101(99)00029-5. Cytokine Growth Factor Rev. 2000. PMID: 10708953 Review.
• Structure and activation of the large latent transforming growth factor-Beta complex.
  Nunes I, Munger J, Harpel JG, Nagano Y, Shapiro R, Gleizes PE, Rifkin DB. Nunes I, et al. J Am Optom Assoc. 1998 Oct;69(10):643-8. J Am Optom Assoc. 1998. PMID: 9805445 Review.

Cited by

• miR-335-3p attenuates transforming growth factor beta 1-induced fibrosis by suppressing Thrombospondin 1.
  Han DH, Shin MK, Sung JS, Kim M. Han DH, et al. PLoS One. 2024 Oct 7;19(10):e0311594. doi: 10.1371/journal.pone.0311594. eCollection 2024. PLoS One. 2024. PMID: 39374214 Free PMC article.
• Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.
  Schmidt D, Endres C, Hoefflin R, Andrieux G, Zwick M, Karantzelis N, Staehle HF, Vinnakota JM, Duquesne S, Mozaffari Jovein M, Pfeifer D, Becker H, Blazar BR, Zähringer A, Duyster J, Brummer T, Boerries M, Baumeister J, Shoumariyeh K, Li J, Green AR, Heidel FH, Tirosh I, Pahl HL, Leimkühler N, Köhler N, de Toledo MAS, Koschmieder S, Zeiser R. Schmidt D, et al. Cancer Res. 2024 Sep 16;84(18):2985-3003. doi: 10.1158/0008-5472.CAN-23-3553. Cancer Res. 2024. PMID: 38885318 Free PMC article.
• Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissections.
  Ganizada BH, Veltrop RJA, Akbulut AC, Koenen RR, Accord R, Lorusso R, Maessen JG, Reesink K, Bidar E, Schurgers LJ. Ganizada BH, et al. Basic Res Cardiol. 2024 Jun;119(3):371-395. doi: 10.1007/s00395-024-01053-1. Epub 2024 May 3. Basic Res Cardiol. 2024. PMID: 38700707 Free PMC article. Review.
• PP2A Affects Angiogenesis via Its Interaction with a Novel Phosphorylation Site of TSP1.
  Thalwieser Z, Fonódi M, Király N, Csortos C, Boratkó A. Thalwieser Z, et al. Int J Mol Sci. 2024 Feb 3;25(3):1844. doi: 10.3390/ijms25031844. Int J Mol Sci. 2024. PMID: 38339122 Free PMC article.

References

1. 1. J Biol Chem. 1989 Jul 15;264(20):12025-8 - PubMed
2. 1. FASEB J. 1992 Nov;6(14):3290-9 - PubMed
3. 1. J Biol Chem. 1988 Oct 5;263(28):14211-5 - PubMed
4. 1. Mol Cell Biol. 1988 Oct;8(10):4162-8 - PubMed
5. 1. Mol Cell Biol. 1988 Oct;8(10):4234-42 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal